Symbiosis C.M.

Personalized Transcatheter Heart Valve Replacement

Health Tech & Life Sciences
Active
Seed Petah Tikva, Israel Founded 2021
Last updated 2026-06-18
Total raised
Last: Undisclosed Round 2025-02
Stage
Seed
Founded
2021
Headcount
16
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Symbiosis C.M. is an innovative medical device company dedicated to solving anatomical variability in valvular heart disease, allowing better fit and better performance for existing medical devices, as well as standalone products for anatomies with great inter-patient variability.

Symbiosis first product is ValSync, the first minimally invasive personalized solution for valve replacement.

Funding history · 5 rounds · — total

2025-02
Undisclosed Round Undisclosed
2024-12
Grant Undisclosed
2023-12
Undisclosed Round Undisclosed
2023-05
Grant Undisclosed
2022-02
Undisclosed Round Undisclosed

Headcount over time

From 3 (2023-11) to 18 (2026-01) · +15 (+500%) · 12 points · source: Finder history + radar grounding
180 2023-11 2026-01

Q&A

What is Symbiosis C.M.'s primary focus?
Symbiosis C.M. is an innovative medical device company focused on solving anatomical variability in valvular heart disease to improve the fit and performance of existing medical devices and develop standalone products for highly variable anatomies.
What is Symbiosis C.M.'s flagship product?
Symbiosis C.M.'s first product is ValSync, which is described as the first minimally invasive personalized solution for valve replacement.
When was Symbiosis C.M. founded?
Symbiosis C.M. was founded in February 2021.
How many employees does Symbiosis C.M. have?
Symbiosis C.M. has 11-50 employees.
What is Symbiosis C.M.'s current funding stage?
Symbiosis C.M. is currently in the Seed funding stage.
Has Symbiosis C.M. received any grants recently?
Yes, Symbiosis C.M. received a Grant in December 2024 and another in May 2023.
Who is the Founder & CEO of Symbiosis C.M.?
Shira Burg is the Founder & CEO of Symbiosis C.M.
What is the primary sector of Symbiosis C.M.?
Symbiosis C.M.'s primary sector is Health Tech & Life Sciences.
Does Symbiosis C.M. hold any patents?
Yes, Symbiosis C.M. holds one patent.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymersComponentsModular
Target customers
Healthcare & Life SciencesMedical Devices Industry
Business model
B2B

Highlights

1 PatentsVerified

Tags

valvescardiologyminimally-invasivemedical-devicesheart-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesymbiosis-cm.com/
LinkedInlinkedin.com/company/82605253

Identifiers & details

Former namesVallus
Founded2021-2
Employees (exact)16

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainsymbiosis-cm.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516348679
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-02-22
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events7 — shares_capital (2), other (1), people (2), annual_report (2)
Registered addressהסיבים 18 פתח תקווה

Recent registry events

DateEvent
2026-05-31הקצאת מניות
2026-05-26שינוי בתקנון
2026-05-25הגדלה של הון רשום
2026-06-11עדכון דירקטורים-הוספת דירקטור
2026-06-09עדכון בעלי תפקידים
2026-01-06דו~ח שנתי-הקצאת מניות
2026-01-06דו~ח שנתי-הפחתת הון מוקצה